 Both tested products will be applied in the vagina, using the dedicated applicator, once a day, preferably at bedtime. To investigate the activity of the products under study, 4 visits will be performed: a baseline visit T0, a visit at the end of the first week-treatment T1, a visit at the end of the wash out period T2 and a final visit at the end of the second week-treatment T3. 